Literature DB >> 16763895

Anaplerotic molecules: current and future.

Henri Brunengraber1, Charles R Roe.   

Abstract

This review presents the concepts of anaplerosis and cataplerosis in relation to the regulation of citric acid cycle operation. Anaplerosis is the re-filling of the catalytic intermediates of the cycle that carry acetyl-CoA as it is oxidized. The main anaplerotic substrates are pyruvate, glutamine/glutamate and precursors of propionyl-CoA (odd-chain fatty acids, specific amino acids, C(5)-ketone bodies). Cataplerosis balances anaplerosis by removing excess intermediates from the citric acid cycle. The properties of the main anaplerotic substrates are reviewed from the point of view of potential clinical applications to the treatment of some inherited and acquired conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763895     DOI: 10.1007/s10545-006-0320-1

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  25 in total

1.  Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate.

Authors:  R R Russell; H Taegtmeyer
Journal:  Am J Physiol       Date:  1991-12

Review 2.  Regulation of hepatic fatty acid oxidation and ketone body production.

Authors:  J D McGarry; D W Foster
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

3.  Replenishment of citric acid cycle intermediates by the purine nucleotide cycle in rat skeletal muscle.

Authors:  J J Aragón; K Tornheim; M N Goodman; J M Lowenstein
Journal:  Curr Top Cell Regul       Date:  1981

Review 4.  Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential.

Authors:  Charles R Roe; Fanny Mochel
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

5.  Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state.

Authors:  E Bassenge; O Sommer; M Schwemmer; R Bünger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

Review 6.  Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion.

Authors:  Michael J MacDonald; Leonard A Fahien; Laura J Brown; Noaman M Hasan; Julian D Buss; Mindy A Kendrick
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01       Impact factor: 4.310

7.  Effect of pyruvate on regional ventricular function in normal and stunned myocardium.

Authors:  R M Mentzer; D G Van Wylen; J Sodhi; R J Weiss; R D Lasley; J Willis; R Bünger; L M Flint
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

8.  Intravenous feeding of the rat with short chain fatty acid esters. II. Monoacetoacetin.

Authors:  R H Birkhahn; J R Border
Journal:  Am J Clin Nutr       Date:  1978-03       Impact factor: 7.045

9.  Propionyl-L-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate.

Authors:  R R Russell; J I Mommessin; H Taegtmeyer
Journal:  Am J Physiol       Date:  1995-01

10.  Assessing the reversibility of the anaplerotic reactions of the propionyl-CoA pathway in heart and liver.

Authors:  Aneta E Reszko; Takhar Kasumov; Bradley A Pierce; France David; Charles L Hoppel; William C Stanley; Christine Des Rosiers; Henri Brunengraber
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

View more
  77 in total

Review 1.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

2.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.

Authors:  Stefan Kölker; Vassili Valayannopoulos; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; S P Nikolas Boy; Marlene Bøgehus Rasmussen; Peter Burgard; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Francesca Furlan; Florian Gleich; Maria Julieta González; Wanda Gradowska; Stephanie Grünewald; Tomas Honzik; Friederike Hörster; Hariklea Ioannou; Anil Jalan; Johannes Häberle; Gisela Haege; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Elaine Murphy; Hélène Ogier de Baulny; Carlos Ortez; Consuelo C Pedrón; Guillem Pintos-Morell; Luis Pena-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Allan M Lund; Angeles Garcia-Cazorla; Angeles Garcia Cazorla
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

3.  Anaplerotic therapy in propionic acidemia.

Authors:  Nicola Longo; Leisa B Price; Eduard Gappmaier; Nancy L Cantor; Sharon L Ernst; Carrie Bailey; Marzia Pasquali
Journal:  Mol Genet Metab       Date:  2017-07-12       Impact factor: 4.797

4.  Innate short-circuiting of mitochondrial metabolism in cardiac hypertrophy: identification of novel consequences of enhanced anaplerosis.

Authors:  Michael N Sack
Journal:  Circ Res       Date:  2009-03-27       Impact factor: 17.367

Review 5.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

Review 6.  Integration of cellular bioenergetics with mitochondrial quality control and autophagy.

Authors:  Bradford G Hill; Gloria A Benavides; Jack R Lancaster; Scott Ballinger; Lou Dell'Italia; Zhang Jianhua; Victor M Darley-Usmar
Journal:  Biol Chem       Date:  2012-12       Impact factor: 3.915

7.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

8.  Characterization of phospholipids in insulin secretory granules and mitochondria in pancreatic beta cells and their changes with glucose stimulation.

Authors:  Michael J MacDonald; Lacmbouh Ade; James M Ntambi; Israr-Ul H Ansari; Scott W Stoker
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

9.  Dipropionylcysteine ethyl ester compensates for loss of citric acid cycle intermediates during post ischemia reperfusion in the pig heart.

Authors:  Takhar Kasumov; Naveen Sharma; Hazel Huang; Rajan S Kombu; Andrea Cendrowski; William C Stanley; Henri Brunengraber
Journal:  Cardiovasc Drugs Ther       Date:  2009-12       Impact factor: 3.727

10.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.